Strategic innovation research for Boehringer Ingelheim Pharma GmbH & Co. KG

Project: Enterprise Lab

A fast and agile response to new digitization challenges is essential for an innovation-driven pharmaceutical company such as Boehringer Ingelheim. When it comes to reorganizing business processes or supporting them with new digital means, technology solutions to enable this are required quickly. Speed is also of the essence for new digital services so the system can be brought to market quickly. This is exactly what the Enterprise Lab offers: An agreed allotment of flexible research and development services over a period of several years, with flexible access.

The work content is largely defined on an as-needed basis according to the customer’s current requirements and issues. Depending on the assignment, the team keeps changing with the appointment of the best experts for the respective topic. The project manager on the other hand is permanently assigned as the central contact for Boehringer Ingelheim. This "research master agreement" tremendously reduces the administrative effort for cooperation.


Services provided by Fraunhofer ISST

Fraunhofer ISST has developed numerous innovations for Boehringer Ingelheim within the Enterprise Lab framework. These range from visible results such as automated illness detection using AI-based analysis to innovations “under the hood” through the optimization and automation of data management tasks, for example in the areas of data quality and transparency.